RE: Rns , assays , incredible. 23 m at 1.51%7 Sep 2022 13:51
Bick,
Absolutely, my preference would be that the remaining % go to a competitor or competitors, if such deals are on the table moving forward. But we don’t know what is happening in the background so it’s hard to comment only speculate / wishful thinking.
I don’t think though a company will be making a move for the remainder of offtake until DFS / RUS numbers are known.
I like you do think that the Chinese got a very good deal, the company thought that it was the best deal so not a lot we can do. Would have loved to know who else they were talking to and what else was on offer to compare. I am not sure if I want Zulu sold or not, still undecided, I guess it depends on the revenues it generates and the effect on the SP.